Anti-Hu ACE2, AC18F, UC, 50ug

This unconjugated monoclonal antibody from STEMCELL Technologies targets human ACE2 (angiotensin-converting enzyme 2), the cell-surface carboxypeptidase that serves as the entry receptor for SARS-CoV-2 and related coronaviruses. Clone AC18F is supplied at 50 µg per vial and is validated for flow cytometry, western blot, and immunohistochemistry workflows, making it a versatile reagent for investigators studying viral entry mechanisms, cardiovascular renin-angiotensin signaling, and pulmonary epithelial biology. Researchers commonly apply this reagent to characterize ACE2 expression across differentiated airway organoids, primary lung tissue, and engineered cell lines, while isotype controls are recommended for accurate compensation and gating. The antibody is intended for research use only and should be refrigerated at 4 °C to preserve activity through multiple freeze-thaw cycles.